|Day Low/High||0.55 / 0.60|
|52 Wk Low/High||0.58 / 4.05|
Holzer & Holzer, LLC is investigating whether Tetraphase Pharmaceuticals, Inc.
Investors in Tetraphase Pharmaceuticals, Inc saw new options become available this week, for the August 17th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 225 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
Submission Supported by Positive Data from IGNITE1 and IGNITE4 Clinical Trials
Investors in Tetraphase Pharmaceuticals, Inc saw new options begin trading this week, for the January 2018 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TTPH options chain for the new January 2018 contracts and identified the following call contract of particular interest.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
- Company plans to advance current oral eravacycline formulation into a phase 2 study in 1H18 -
Investors in Tetraphase Pharmaceuticals, Inc saw new options become available this week, for the May 2018 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 238 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
The most recent short interest data has been released for the 08/31/2017 settlement date, which shows a 961,370 share increase in total short interest for Tetraphase Pharmaceuticals, Inc , to 3,889,264, an increase of 32.83% since 08/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Both TP-6076 and TP-271 Demonstrated Favorable Pharmacokinetic and Safety Profiles, Supporting Advancement into Multiple-Ascending Dose Studies
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.